Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Sabarina Ramanathan"'
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Externí odkaz:
https://doaj.org/article/36584028bd504ed4876a04d15aab7763
Publikováno v:
Case Reports in Cardiology, Vol 2017 (2017)
The efficacy of novel oral anticoagulants (NOACs) in preventing deep venous thrombosis (DVT) has been established in large multicenter trials. Predictable pharmacokinetics, avoidance of routine laboratory monitoring, and lesser drug interactions have
Externí odkaz:
https://doaj.org/article/178826bddf074f5ebb8c9d2638152577
Publikováno v:
World Journal of Clinical Oncology
Spurred by better understanding of disease biology, improvements in molecular diagnostics, and the development of targeted therapies, the treatment of acute myeloid leukemia (AML) has undergone significant evolution in recent years. Arguably, the mos
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
The development of tyrosine kinase inhibitors (TKIs) in the early 2000s revolutionized the therapeutic landscape for chronic phase (CP) chronic myeloid leukemia (CML). Interferon alpha was previously the standard treatment for patients with CP CML pr
Publikováno v:
Case Reports in Cardiology
Case Reports in Cardiology, Vol 2017 (2017)
Case Reports in Cardiology, Vol 2017 (2017)
The efficacy of novel oral anticoagulants (NOACs) in preventing deep venous thrombosis (DVT) has been established in large multicenter trials. Predictable pharmacokinetics, avoidance of routine laboratory monitoring, and lesser drug interactions have
Autor:
Rabia Khan, Avani Yenamandra, Sabarina Ramanathan, Aparna Vuppala, Kristine Ward, Hugo R. Lara-Martinez, Khine Shan, Ahmed Safa, Michael Joseph McCormack, Shaun Bryan Hanson, Michael Styler
Publikováno v:
Journal of Clinical Oncology. 37:75-75
75 Background: Inpatient chemotherapy requires an interdisciplinary approach to achieve shorter hospital stays and decrease cost. A quality improvement project at Hahnemann University Hospital was undertaken to identify delays in the process from adm
Autor:
Stuthi Perimbeti, Kristine Ward, Kevin Ye Hou, Pamela Crilley, Sabarina Ramanathan, Michael Styler, Adonas Woodard, David Topolsky, Daniel Kyung
Publikováno v:
Blood. 132:5889-5889
Introduction: Case reports have suggested that there is an increased risk of hematological malignancies with sickle cell disease (SCD). We aimed to investigate the prevalence and mortality of select hematological malignancies, including: acute myeloi
Autor:
Kristine Ward, Adonas Woodard, Sabarina Ramanathan, Stuthi Perimbeti, Daniel Kyung, Priyadarshini Pathak, Kevin Ye Hou, Michael Styler, Rishi Shrivastav
Publikováno v:
Blood. 132:4701-4701
Introduction: According to the National Center for Health Statistics, there was a twenty-one percent increase in deaths from drug overdose in the USA, with opioids contributing to about two-thirds of these deaths. Despite nationwide efforts to reduce
Autor:
Kristine Ward, Qian Wang, Sabarina Ramanathan, Michael Styler, Adonas Woodard, Pamela Crilley, Stuthi Perimbeti, Kevin Ye Hou, Daniel Kyung
Publikováno v:
Blood. 132:5886-5886
Introduction: Sickle cell disease (SCD) is a chronic and debilitating disorder that affects approximately 100,000 Americans and results in the development of significant complications, leading to high numbers of hospitalizations, healthcare cost and
Autor:
Mohammad H. Rahbar, Jaroslaw Aronowski, Doha Ayish, James C. Grotta, Ali E. Denktas, Chunyan Cai, Sabarina Ramanathan, Anjail Z Sharrief, Sean I Savitz, Renga Pandurengan, Ritvij Bowry, Tzu-Ching Wu, M.Rick Sline, Amrou Sarraj, Xiurong Zhao, Andrew D. Barreto, Nicole R. Gonzales, Nneka Ifejika
Publikováno v:
Stroke. 46
Background: Few studies have reported electrocardiographic (ECG) changes in patients with intracerebral hemorrhage (ICH). We performed a randomized controlled trial evaluating the safety of pioglitazone (PIO) versus placebo in patients with ICH (NCT0